Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway
Miaomiao Cai, Hanning Li, Runfa Chen, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 2009-2024
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease
Lucia Longhitano, Alfio Distefano, Nicolò Musso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature
yang Wang, Dingyuan Wang, Kena Bu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer
Xiaoyi Lin, Lijuan Guo, Xin Lin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
MRPL24 drives breast cancer metastasis and stemness by targeting c-MYC, BRD4, and STAT3
Abdul J. Khan, Islam Uddin Khan, Shad Man, et al.
3 Biotech (2025) Vol. 15, Iss. 2
Closed Access
Mitochondrial Ribosomal Proteins and Cancer
Huiyi Wu, Xiaowei Zhu, Huilin Zhou, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 96-96
Open Access
A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients
Xiangwei Zhang, Wei Dong, Jishuai Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 32
RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors
Jiaoyan Ma, Liankun Sun, Weinan Gao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma
Chengcheng Tong, Wei Wang, Chiyi He
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity
Gong-Kai Huang, Chao‐Cheng Huang, Chih‐Hsiung Kang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1776-1776
Open Access | Times Cited: 8
Heterogeneity and dynamic of EMT through the plasticity of ribosome and mRNA translation
Chloé Morin, Caroline Moyret‐Lalle, Hichem C. Mertani, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188718-188718
Open Access | Times Cited: 13
Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma
Xiaoqing Ma, Zilin Deng, Zhen Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes
Sayan Kundu, Rajendra Rohokale, Chuwei Lin, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 7, pp. 100570-100570
Open Access | Times Cited: 2
Potential of Mitochondrial Ribosomal Genes as Cancer Biomarkers Demonstrated by Bioinformatics Results
Shunchao Bao, Xinyu Wang, Mo Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer
Hongshan Ye, Ning Zhang
Computational and Mathematical Methods in Medicine (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 15
Microfluidic single-cell migration chip reveals insights into the impact of extracellular matrices on cell movement
Mengli Zhou, Yushu Ma, Edwin C. Rock, et al.
Lab on a Chip (2023) Vol. 23, Iss. 21, pp. 4619-4635
Open Access | Times Cited: 5
Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma
Haoyu Ruan, Zhe Wang, Yue Zhai, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 102972-102972
Open Access | Times Cited: 11
Mendelian Randomization Study Reveals a Predicted Relationship between Sensorineural Hearing Loss and Mitochondrial Proteins
Jiangyu Yan, Linrong Wu, Mengmeng Zheng, et al.
Otology & Neurotology (2024) Vol. 45, Iss. 9, pp. e655-e663
Closed Access | Times Cited: 1
MRPL13 is a metastatic and prognostic marker of breast cancer: A silico analysis accompanied with experimental validation
Dai Pei, Yan’an Chen, Xiao Zhang, et al.
Gene (2024) Vol. 932, pp. 148908-148908
Open Access | Times Cited: 1
Mitochondrial ribosomal proteins in metastasis and their potential use as prognostic and therapeutic targets
Jasmine M Bacon, Johanna L. Jones, Guei‐Sheung Liu, et al.
Cancer and Metastasis Reviews (2024)
Open Access | Times Cited: 1
Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
Daniel Pouliquen, Alice Boissard, Cécile Henry, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Role of mitochondrial translation in remodeling of energy metabolism in ER/PR(+) breast cancer
Emine C. Koc, Fatih C. Koc, Funda Kartal, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Identification of a novel therapeutic target for lung cancer: Mitochondrial ribosome protein L9
Xinyuan Li, Xinyu He, Hong Zhao, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154625-154625
Closed Access | Times Cited: 2
[High expression of MRPL13 promotes cell cycle progression and proliferation of gastric cancer cells by inhibiting p53 signaling to affect long-term prognosis].
Luyao Wang, Yuchen Xia, Zhiren Zhang, et al.
PubMed (2023) Vol. 43, Iss. 9, pp. 1558-1566
Closed Access | Times Cited: 2
In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized
Yan Liang, Shuo He, Yiyi Tan, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23582-e23582
Open Access | Times Cited: 2
Identification of a prognostic gene signature based on invasion-related genes in breast cancer
Yicong Niu, Xinliang Zhu, Dachang Ma, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top